Evidence map›Paper›PMID 32240467›Full record

ArticleMolecular biology reports2020

Mechanism of rutin mediated inhibition of insulin amyloid formation and protection of Neuro-2a cells from fibril-induced apoptosis.

V P Mahendra, K Yogendra Prasad, P Ganesan, Ravi Kumar

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

V P MahendraDepartment of Molecular Nutrition, CSIR-Central Food Technological Research Institute (CFTRI), Mysore, 570020, Karnataka, India.
K Yogendra PrasadDepartment of Molecular Nutrition, CSIR-Central Food Technological Research Institute (CFTRI), Mysore, 570020, Karnataka, India.
P GanesanDepartment of Molecular Nutrition, CSIR-Central Food Technological Research Institute (CFTRI), Mysore, 570020, Karnataka, India.
Ravi KumarDepartment of Molecular Nutrition, CSIR-Central Food Technological Research Institute (CFTRI), Mysore, 570020, Karnataka, India. ravik@cftri.res.in.ORCID http://orcid.org/0000-0001-8441-032X
Central Food Technological Research Institute · IN

Funding

Council of Scientific and Industrial Research, India Council of Scientific and Industrial Research, India (Council of Scientific and Industrial Research, India (12th Five Year Plan Project NUTRI-ARM (BSC0404)
6 · The paper itself

Abstract

Many metabolic and neurodegenerative diseases are associated with protein misfolding and aggregation. Insulin a key hormone, under certain conditions aggregates and forms pathological amyloid fibrils. Several polyphenols have been studied extensively to elucidate their inhibitory effect on amyloid formation. In the present study, we used insulin as an amyloid model to test the mechanism and efficacy of rutin as an anti-amyloidogenic molecule. By using electron microscopy, dynamic light scattering and circular dichroism spectroscopy, we show that rutin inhibits the insulin aggregate and fibril formation. Further, rutin interacts with insulin directly and inhibits fibril formation in a dose-dependent manner as demonstrated by micro scale thermophoresis experiments. The molecular docking study predicted the potential binding pocket of rutin at the interface of chain A and chain B of insulin thereby preventing it from forming the aggregates. Since, rutin is a natural anti-oxidant, we studied its role in diminishing amyloid fibril induced cytotoxicity and apoptosis. Rutin, decreases the insulin amyloid fibrils-induced Neuro-2a cytotoxicity by reducing reactive oxygen species (ROS) levels which in turn downregulates Bax and upregulates Bcl-2 and pBad proteins. These findings suggest the potential action of rutin in preventing protein misfolding, cell death, and serves as a lead structure to design novel anti-amyloidosis compounds.

Indexed as

AmyloidAmyloidosisAnimalsApoptosisCell DeathHumansInsulinMiceMolecular Docking SimulationRutinAmyloidInsulinRutinCytotoxicityFibrilsRutin

Identifiers

PMID32240467
OpenAlexW3014667065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.